SCHEMBL1825515

SCHEMBL1825515

CC(C)(C)OC(=O)NC(O)Cc1ccc(OS(=O)(=O)c2ccccc2)cc1.c1ccc(COCc2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 9/20 0.52
BCL2 P10415 1/20 0.52
PPARA Q07869 2/20 0.49
ABCB1 P08183 1/20 0.47
KDM4E B2RXH2 1/20 0.46
KDM4A O75164 1/20 0.46
PPARG P37231 1/20 0.45
CTSS P25774 2/20 0.45
ATM Q13315 1/20 0.44
ALDH1A1 P00352 2/20 0.44
LMNA P02545 2/20 0.44
PKM P14618 2/20 0.44
HPGD P15428 2/20 0.44
TSHR P16473 2/20 0.44
HTT P42858 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
AGTR1 P30556 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1825467 0.94 P2RX7 (0.59) P2RX7BCL2PPARAKDM4EKDM4A
SCHEMBL1824977 0.94 ABCB1 (0.52) P2RX7BCL2ABCB1KDM4EKDM4A
Methoxymethane SCHEMBL1826599 0.92 ABCB1 (0.50) P2RX7BCL2ABCB1KDM4EKDM4A
SCHEMBL1824073 0.90 PPARA (0.51) P2RX7BCL2PPARAABCB1PPARG
SCHEMBL1826284 0.88 P2RX7 (0.51) P2RX7BCL2PPARAABCB1KDM4E
SCHEMBL1826283 0.87 PPARA (0.53) P2RX7BCL2PPARAABCB1KDM4E
SCHEMBL1825513 0.85 P2RX7 (0.53) P2RX7BCL2PPARAABCB1KDM4E
SCHEMBL1822496 0.84 P2RX7 (0.54) P2RX7BCL2ABCB1KDM4EKDM4A
SCHEMBL1824451 0.84 P2RX7 (0.63) P2RX7BCL2ABCB1KDM4EKDM4A
SCHEMBL1824453 0.84 P2RX7 (0.63) P2RX7BCL2ABCB1KDM4EKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 P2RX7 3606/4885BCL2 1414/4885PPARA 3865/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 P2RX7 2747/4885BCL2 1908/4885PPARA 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.